Terra Innovatum and GSR III Acquisition Corp. Announce Shareholder Approval of Business Combination with $130 Million of Total Proceeds Expected at Close
Terra Innovatum (to trade as NKLR) and GSR III Acquisition Corp. (Nasdaq: GSRT) announced GSRT shareholders approved the business combination on October 7, 2025. The transaction is expected to deliver $130 million of trust and equity financing at close to fund licensing, first-of-a-kind (FOAK) SOLO™ micro-modular reactor construction, and initial commercialization efforts. The combined company will be named Terra Innovatum Global N.V. and ordinary shares are expected to trade on Nasdaq under the ticker NKLR, subject to closing and listing conditions. Closing is expected in the coming days pending satisfaction or waiver of conditions.
Terra Innovatum (a commerciarsi come NKLR) e GSR III Acquisition Corp. (Nasdaq: GSRT) hanno annunciato che gli azionisti di GSRT hanno approvato la business combination il 7 ottobre 2025. La transazione dovrebbe fornire 130 milioni di dollari di finanziamento fiduciario e di equity al closing per finanziare la concessione di licenze, la costruzione di un reattore SOLO™ micro-modulare di prima generazione (FOAK) e le prime attività di commercializzazione. La società combinata sarà denominata Terra Innovatum Global N.V. e le azioni ordinarie dovrebbero essere negoziate al Nasdaq con il ticker NKLR, salvo condizioni di chiusura e di quotazione. La chiusura è prevista nei prossimi giorni, soggetta all'adempimento o rinuncia delle condizioni.
Terra Innovatum (para comerciar como NKLR) y GSR III Acquisition Corp. (Nasdaq: GSRT) anunciaron que los accionistas de GSRT aprobaron la fusión empresarial el 7 de octubre de 2025. Se espera que la transacción proporcione 130 millones de dólares de financiamiento de confianza y de capital a la fecha de cierre para financiar la concesión de licencias, la construcción de un micro-reactor modulado en SOLO™ de primera generación (FOAK) y los esfuerzos de comercialización inicial. La empresa combinada llevará el nombre Terra Innovatum Global N.V. y se espera que las acciones ordinarias coticen en Nasdaq bajo el símbolo NKLR, sujeto a las condiciones de cierre y listado. Se espera que el cierre tenga lugar en los próximos días, pendiente del cumplimiento o renuncia de las condiciones.
Terra Innovatum( NKLR로 거래) 및 GSR III Acquisition Corp. (나스닥: GSRT)는 GSRT 주주들이 2025년 10월 7일에 사업 결합을 승인했다고 발표했습니다. 거래는 면허 자금 조달, 최초의 유일무이한(FOAK) SOLO™ 소형 모듈러 원자로 건설 및 초기 상용화 노력을 지원하기 위해 1억 3000만 달러의 트러스트 및 자본 금융을 제공할 것으로 기대됩니다. 합병 회사의 이름은 Terra Innovatum Global N.V.으로 정해지며 보통주는 Nasdaq에서 NKLR 티커로 거래될 예정이며, 이는 종결 및 상장 조건에 따릅니다. 종결은 조건의 충족 또는 포기에 따라 앞으로 며칠 내에 이뤄질 것으로 예상됩니다.
Terra Innovatum (à négocier sous le nom NKLR) et GSR III Acquisition Corp. (Nasdaq : GSRT) ont annoncé que les actionnaires de GSRT ont approuvé la fusion d’entreprise le 7 octobre 2025. La transaction devrait fournir 130 millions de dollars de financement fiduciaire et équité au closing pour financer l’octroi de licences, la construction d’un réacteur SOLO™ micro-modulaire de première génération (FOAK) et les efforts de commercialisation initiaux. La société fusionnée sera nommée Terra Innovatum Global N.V. et les actions ordinaires devraient être négociées sur le Nasdaq sous le symbole NKLR, sous réserve des conditions de closing et d’admission. Le closing est attendu dans les prochains jours, sous réserve de satisfaction ou de renonciation des conditions.
Terra Innovatum (unter dem Handelsnamen NKLR) und GSR III Acquisition Corp. (Nasdaq: GSRT) gaben bekannt, dass die GSRT-Aktionäre der Transaktion am 7. Oktober 2025 zugestimmt haben. Die Transaktion wird voraussichtlich 130 Mio. US-Dollar an Treuhand- und Eigenkapitalfinanzierung bei Abschluss bereitstellen, um Lizenzen zu finanzieren, den Bau eines FOAK SOLO™-mikro-modularen Reaktors zu ermöglichen und erste Kommerzialisierungsmaßnahmen zu unterstützen. Das zusammengeschlossene Unternehmen wird den Namen Terra Innovatum Global N.V. tragen und gewöhnliche Aktien werden voraussichtlich an der Nasdaq unter dem Ticker NKLR gehandelt, vorbehaltlich Abschluss- und Listungsbedingungen. Der Abschluss wird in den kommenden Tagen erwartet, vorbehaltlich der Erfüllung oder Verzichtserklärungen von Bedingungen.
Terra Innovatum (للتداول باسم NKLR) و GSR III Acquisition Corp. (ناسداك: GSRT) أعلنوا أن مساهمي GSRT وافقوا على الدمج التجاري في 7 أكتوبر 2025. من المتوقع أن توفر الصفقة 130 مليون دولار من تمويل الثقة حقوق الملكية عند الإغلاق لتمويل منح التراخيص، وبناء مفاعل SOLO™ Micro-Modular من النوع الأول (FOAK)، وجهود التسويق الأولية. ستُسمى الشركة المدمجة Terra Innovatum Global N.V. ومن المتوقع أن تُتداول الأسهم العادية في ناسداك بالرمز NKLR، رهناً بإغلاق وشروط الإدراج. من المتوقع الإغلاق خلال الأيام المقبلة عقب استيفاء الشروط أو التنازل عنها.
Terra Innovatum（以 NKLR 为交易名） 与 GSR III Acquisition Corp.（纳斯达克：GSRT） 宣布 GSRT 股东已于 2025 年 10 月 7 日 通过了商业合并。交易预计在交割时提供 1.3 亿美元 的信托及股权融资，用于资助许可、首个 FOAK SOLO™ 微模组化反应堆的建设，以及初步商业化工作。合并后的公司将命名为 Terra Innovatum Global N.V.，普通股预计在 Nasdaq 以代码 NKLR 交易，具体以完成与上市条件为准。预计在未来几日内完成，前提是满足或放弃相关条件。
- $130 million in trust and equity financing expected at close
- Proceeds expected to fund NRC licensing and FOAK reactor build
- Nasdaq listing expected under ticker NKLR
- Close-pro forma balance sheet expected to support commercial scale-up and supply chain
- Business Combination is subject to closing and listing conditions
- Commercialization target of 2028 is a stated target and not guaranteed
Insights
Transaction provides a clear near-term capital runway and public listing to fund licensing and FOAK delivery.
Terra Innovatum completed shareholder approval for a business combination that brings
The key dependencies are explicit closing conditions, NASDAQ listing requirements, and the company’s use of proceeds to finish NRC licensing and build a first-of-a-kind (FOAK) unit. The announcement ties funds directly to licensing, production, and deployment work, reducing short-term funding risk but leaving execution and regulatory milestones as primary risks.
Watch the actual close (expected in the coming days), confirmation of receipt of
Funding targets NRC licensing and FOAK deployment, moving commercialization timelines into an actionable phase.
Terra Innovatum frames the proceeds as sufficient to complete NRC licensing and to build and operate its first SOLO™ micro-modular reactor, which supports its stated commercialization timetable of
Main risks remain regulatory approval, demonstrated FOAK performance, and supply‑chain execution despite an established supplier base. The company’s claims are milestone-driven; successful NRC interactions and completion of the FOAK program are the concrete metrics that will validate the financing’s impact.
Key near-term items to watch include confirmation of closing funds, NRC licensing progress updates, and any disclosed timelines or milestones tied to FOAK construction and commercialization over the next 36 months.
$130 million in trust and equity financing proceeds to provide significant financial runway to complete first-of-a-kind SOLO™ micro-modular reactor licensing, production, and deployment- Combination of capital-light business model and strong cash position at close expected to accelerate growth, commercial scale-up, and supply chain enhancements
- Ordinary shares expected to trade on Nasdaq under the symbol “NKLR”
NEW YORK and AUSTIN, Texas, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl ("Terra Innovatum" or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. ("GSRT") (Nasdaq: GSRT), a publicly traded special purpose acquisition company, today announced that GSRT shareholders have voted to approve the previously announced business combination (“Business Combination”) with Terra Innovatum and all of the other proposals presented at GSRT’s Extraordinary General Meeting of Shareholders held on October 7, 2025. GSRT is no longer accepting redemption reversal requests.
Alessandro Petruzzi, CEO of Terra Innovatum, said, “We are excited that shareholders voted to approve our transaction and support our mission to deliver low-cost, zero-carbon, and reliable energy to the world. We are one step closer to becoming the first publicly traded nuclear reactor developer that has designed a scalable microreactor that can run on widely available LEU fuel and off-the-shelf components and is on track for commercialization in the U.S. by 2028. The proceeds from this transaction are expected to provide us with more than sufficient capital to complete the NRC licensing process and build and operate our FOAK reactor, positioning us for accelerated growth. Thank you to all the shareholders that have invested in our vision – we are confident that we have the right technology, team, and strategy in place to deliver long-term value for investors, customers, and the communities we serve.”
Giordano Morichi, Partner, Chief Business Development Officer & Investor Relations at Terra Innovatum, added, “The strength of our balance sheet at close will enable us to not only bring SOLO™ to market, but also to support scaling our commercial operations and strengthening our supply chain, which has already been established. We are particularly proud to have the backing of thousands of investors worldwide who believe in our mission, our technology, and our ability to deliver clean, reliable nuclear energy.”
Subject to the satisfaction or waiver of certain closing conditions, the Business Combination is expected to close in the coming days. The post-combination company will operate under the name Terra Innovatum Global N.V., and its ordinary shares are expected to trade on Nasdaq under the ticker symbol “NKLR,” subject to the satisfaction of all other listing conditions.
ABOUT GSR III
GSR III Acquisition Corp. is a blank check company incorporated in the Cayman Islands with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating businesses. GSRT is led by a highly experienced sponsor team with a strong track record in SPAC transactions, having previously sponsored two SPACs and advised on over 20 successful SPAC completions. The company's management team includes Co-Chief Executive Officers Mr. Gus Garcia and Mr. Lewis Silberman, President and Chief Financial Officer Mr. Anantha Ramamurti, and Chief Business Development Officer Mr. Yuya Orime.
ABOUT TERRA INNOVATUM & SOLO™
Terra Innovatum's mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time.
Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.
It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.
SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.
To learn more, visit: www.terrainnovatum.com.
CONTACTS
Giordano Morichi
Partner, Chief Business Development Officer & Investor Relations
Terra Innovatum Srl
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com
Anantha Ramamurti
President, Chief Financial Officer
GSR III Acquisition Corp
E: anantha@gsrspac.com
P: (949) 468-7434
Nicholas Hresko-Staab
Vice President
Investor & Media Relations
Alliance Advisors IR
E: TerraIR@allianceadvisors.com
IMPORTANT INFORMATION FOR SHAREHOLDERS
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.
FORWARD LOOKING STATEMENTS
The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on GSRT and the other Registrant Parties. There can be no assurance that future developments affecting GSRT and the other Registrant Parties will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the Business Combination; (2) the outcome of any legal proceedings that may be instituted against GSRT, any of the Registrant Parties, the combined company or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the inability to complete the Business Combination due to the failure to satisfy all conditions to closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (5) the ability of Terra Innovatum to meet stock exchange listing standards following the consummation of the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations of Terra Innovatum as a result of the announcement and consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Business Combination, including the reorganization described in the business combination agreement; (9) changes in applicable laws or regulations; (10) the possibility that the Registrant Parties or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the amount of redemption requests made by GSRT shareholders and (12) other risk factors described herein as well as the risk factors and uncertainties described in the Form S-4 and GSRT’s other filings with the SEC. In addition, there may be additional risks that neither GSRT nor any of the other Registrant Parties presently know, or that GSRT or the other Registrant Parties currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.
None of GSRT, the other Registrant Parties, or any of their respective affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. GSRT, the other Registrant Parties and their respective affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom. Further, the information contained herein is preliminary, is provided for discussion purposes only, is only a summary of key information, is not complete and is subject to change without notice.
In addition, the information contained in this press release is provided as of the date hereof and may change, and neither GSRT nor the other Registrant Parties undertakes any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.
FAQ
What did GSRT shareholders approve on October 7, 2025 regarding Terra Innovatum (GSRT)?
How much financing will Terra Innovatum receive at close and what is it for (GSRT/NKLR)?
When is Terra Innovatum expecting Nasdaq trading under the ticker NKLR?
What is Terra Innovatum's commercialization timeline after the GSRT deal (GSRT/NKLR)?
Are there any immediate investor actions after the GSRT shareholder vote?
